Cognitive impairment in depression: recent advances and novel treatments
Giulia Perini,1,2 Matteo Cotta Ramusino,1,2 Elena Sinforiani,1 Sara Bernini,1 Roberto Petrachi,3 Alfredo Costa1,21Center of Cognitive and Behavioral Disorders, IRCCS Fondazione Mondino, National Institute of Neurology, Pavia, Italy; 2Department of Brain and Behavior, University of Pavia, Pavia, Ital...
Guardado en:
Autores principales: | Perini G, Cotta Ramusino M, Sinforiani E, Bernini S, Petrachi R, Costa A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/074d8d4d7d934a26b55a54f89ef1d1ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of cognitive impairment in patients with major depressive disorder in remission
por: Mustafa Ali, et al.
Publicado: (2021) -
Mind your state: Insights into antidepressant nonadherence
por: De Wet Wolmarans, et al.
Publicado: (2016) -
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
por: McIntyre RS, et al.
Publicado: (2021) -
The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
por: Li G, et al.
Publicado: (2016) -
5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients
por: Dong ZQ, et al.
Publicado: (2016)